Home Data Calendar Blog

STIM

Tables

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Common Stock Value		0.29	0.29	0.29	0.28	0.27	0.27	0.27	0.27	0.26	0.26	0.26	0.26	0.19	0.19	0.19	0.19	0.19	0.19	0.18	0.18	0.18	0.18	0.00	NA	0.00	NA	NA	NA
Earnings Per Share Basic		-0.18	-0.33	-0.17	-0.38	-0.30	-0.28	-0.39	-0.41	-0.28	-0.31	-0.29	-0.31	-0.19	-0.18	-0.41	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Earnings Per Share Diluted		-0.18	-0.33	-0.17	-0.38	-0.30	-0.28	-0.39	-0.41	-0.32	-0.28	-0.29	-0.31	-0.19	-0.18	-0.41	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Revenue From Contract With Customer Excluding Assessed Tax		20.31	17.88	17.61	15.54	18.20	16.50	16.33	14.18	15.02	13.80	14.20	12.29	15.58	12.45	9.74	11.48	17.36	16.00	16.57	12.73	15.63	13.74	13.25	10.15	12.11	10.49	10.31	7.53
Revenues		20.31	17.88	17.61	15.54	18.20	16.50	16.33	14.18	15.02	13.80	14.20	12.29	15.58	12.45	9.74	11.48	17.36	16.00	16.57	12.73	15.63	13.74	13.25	10.15	12.11	10.49	10.31	7.53
Cost Of Revenue		4.54	6.12	4.84	4.14	4.39	3.57	4.04	3.48	3.54	3.14	2.75	2.22	3.76	2.66	2.32	2.81	4.22	4.19	4.17	2.81	3.71	3.03	3.25	2.46	2.96	2.64	2.50	1.54
Cost Of Goods And Services Sold		4.54	6.12	4.84	4.14	4.39	3.57	4.04	3.48	3.54	3.14	2.75	2.22	3.76	2.66	2.32	2.81	4.22	4.19	4.17	2.81	3.71	3.03	3.25	2.46	2.96	2.64	2.50	1.54
Gross Profit		15.77	11.76	12.77	11.40	13.81	12.93	12.29	10.70	11.48	10.65	11.45	10.07	11.82	9.79	7.42	8.66	13.14	11.81	12.40	9.92	11.92	10.70	10.01	7.70	9.15	7.86	7.81	5.99
Operating Expenses		20.20	20.64	20.12	21.30	21.54	20.38	22.09	20.83	18.39	17.84	18.02	16.98	14.48	12.21	14.28	19.03	20.08	18.14	19.01	16.98	17.59	15.04	15.24	12.30	13.38	10.66	10.38	9.98
Research And Development Expense		2.21	2.15	2.36	2.79	3.14	2.35	2.04	1.80	1.74	1.57	2.29	2.31	2.11	1.95	2.12	3.02	4.25	3.49	3.22	2.79	2.22	2.12	2.33	1.55	1.92	1.84	2.15	2.03
General And Administrative Expense		6.28	6.34	6.20	6.61	6.39	6.39	6.36	6.38	6.33	6.43	6.68	6.10	4.73	4.21	4.01	5.29	4.31	4.29	4.26	4.60	4.71	3.24	3.08	2.64	2.84	2.26	1.84	1.64
Selling And Marketing Expense		11.72	12.14	11.56	11.90	12.01	11.64	13.69	12.65	10.31	9.83	9.04	8.56	7.63	6.05	8.15	10.72	11.52	10.36	11.52	9.59	10.65	9.67	9.84	8.11	8.63	6.57	6.40	6.31
Operating Income Loss		-4.43	-8.87	-7.35	-9.91	-7.73	-7.45	-9.80	-10.13	-6.91	-7.18	-6.56	-6.91	-2.66	-2.42	-6.86	-10.37	-6.94	-6.33	-6.61	-7.06	-5.66	-4.33	-5.24	-4.61	-4.23	-2.81	-2.58	-3.99
Interest Expense		1.84	1.18	1.14	1.25	1.21	1.06	1.00	0.98	1.06	0.99	0.98	0.98	1.01	1.00	0.99	1.52	0.91	0.93	0.93	0.92	0.94	0.93	0.90	0.92	0.74	0.81	0.71	0.55
Interest Expense Debt		1.70	1.10	1.00	1.10	1.10	0.90	0.80	0.80	0.80	0.80	0.80	0.80	0.80	0.80	0.80	1.40	0.70	0.70	0.70	0.70	0.80	0.70	0.70	0.70	0.50	0.50	0.50	NA
Interest Paid Net		1.67	1.04	1.01	1.06	1.02	0.89	0.82	0.81	0.83	0.83	0.82	0.81	0.83	0.83	0.82	1.40	0.71	0.75	0.76	0.74	0.73	0.72	0.71	0.63	0.55	0.50	NA	NA
Allocated Share Based Compensation Expense		1.63	1.85	2.03	1.80	2.11	2.18	2.20	2.25	1.70	1.96	2.01	2.20	1.52	1.05	0.65	1.20	0.98	0.93	1.02	0.50	0.38	1.03	0.19	0.14	0.20	0.10	0.16	NA
Profit Loss		-5.38	-9.39	-4.90	-10.52	-8.29	-7.61	-10.42	-10.84	-7.64	-8.15	-7.53	-7.88	-3.66	-3.42	-7.76	-12.61	-7.55	-6.87	-7.09	-7.53	-6.14	-4.96	-7.50	-5.50	-4.92	-3.75	NA	NA
Net Income Loss		-5.38	-9.39	-4.90	-10.52	-8.29	-7.61	-10.42	-10.84	-7.64	-8.15	-7.53	-7.88	-3.66	-3.42	-7.76	-12.61	-7.55	-6.87	-7.09	-7.53	-6.14	-4.96	-7.50	-5.50	-4.92	-3.75	-2.87	-4.51

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Assets		115.83	92.99	100.39	103.60	116.88	119.23	122.95	129.94	141.22	143.07	148.10	152.31	78.66	78.34	79.99	88.45	100.17	105.48	109.43	113.44	117.02	118.98	28.34	NA	38.94	NA	NA	NA
Liabilities		81.64	55.05	54.91	55.26	59.82	56.24	54.53	53.35	56.05	51.99	50.93	50.34	53.16	50.86	50.55	51.94	52.32	51.15	49.61	48.02	45.98	42.63	46.48	NA	44.45	NA	NA	NA
Liabilities And Stockholders Equity		115.83	92.99	100.39	103.60	116.88	119.23	122.95	129.94	141.22	143.07	148.10	152.31	78.66	78.34	79.99	88.45	100.17	105.48	109.43	113.44	117.02	118.98	28.34	NA	38.94	NA	NA	NA
Stockholders Equity		34.19	37.94	45.48	48.34	57.06	62.99	68.42	76.60	85.17	91.08	97.17	101.97	25.49	27.48	29.44	36.51	47.85	54.33	59.82	65.42	71.04	76.35	-205.27	-197.97	-192.65	NA	NA	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Assets Current		93.79	71.01	77.68	81.11	98.77	101.10	95.08	103.11	115.33	119.45	134.88	138.95	65.01	65.20	67.21	76.43	88.45	95.91	101.30	106.04	114.47	116.74	26.00	NA	37.01	NA	NA	NA
Cash And Cash Equivalents At Carrying Value		59.68	35.85	45.91	55.44	70.34	73.70	70.93	80.84	94.14	99.43	115.78	121.28	48.96	50.72	54.00	63.65	75.71	82.37	89.64	96.15	104.58	106.76	14.54	NA	29.15	NA	26.23	NA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents		59.68	35.85	45.91	55.44	70.34	73.70	70.93	80.84	94.14	99.43	115.78	121.28	48.96	50.72	54.00	63.65	75.71	82.37	89.64	96.15	104.58	106.76	14.54	20.35	29.15	24.15	NA	NA
Accounts Receivable Net Current		15.78	15.02	13.14	9.45	13.59	11.96	11.39	8.25	7.71	7.75	9.00	6.96	7.17	5.56	6.64	6.25	6.57	7.55	7.56	5.67	5.62	5.28	4.72	NA	4.27	NA	NA	NA
Inventory Net		8.09	9.74	8.87	9.14	8.90	8.57	7.18	7.55	6.56	5.36	5.39	5.40	3.72	3.78	3.33	2.88	2.77	2.92	2.55	2.41	2.43	2.61	2.44	NA	2.47	NA	NA	NA
Prepaid Expense And Other Assets Current		4.77	5.23	4.50	2.22	2.17	3.04	1.62	2.59	3.09	3.45	1.45	2.24	2.19	2.66	1.09	1.80	1.83	1.99	1.06	1.63	1.84	2.08	4.29	NA	1.12	NA	NA	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Property Plant And Equipment Gross		4.83	5.61	5.48	5.20	5.05	5.03	4.84	4.48	3.76	3.43	3.14	3.25	3.13	3.13	3.11	3.20	3.31	3.19	3.25	3.30	3.39	3.32	3.42	NA	3.19	NA	NA	NA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment		2.82	3.54	3.37	3.21	3.06	2.92	2.78	2.65	2.54	2.51	2.43	2.39	2.40	2.35	2.28	2.24	2.21	2.19	2.15	2.09	2.02	1.98	1.93	NA	1.83	NA	NA	NA
Property Plant And Equipment Net		2.01	2.07	2.11	1.99	1.99	2.11	2.07	1.82	1.22	0.92	0.71	0.87	0.73	0.79	0.83	0.96	1.11	1.01	1.10	1.21	1.38	1.34	1.49	NA	1.36	NA	NA	NA
Other Assets Noncurrent		4.43	4.09	4.04	3.49	3.65	3.56	3.25	2.84	2.22	2.15	1.98	1.96	1.87	1.89	1.92	1.35	1.30	1.08	1.28	1.39	1.17	0.90	0.85	NA	0.57	NA	NA	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Liabilities Current		19.81	15.34	15.03	15.13	33.20	25.14	18.94	13.18	15.70	47.81	11.58	10.91	13.68	45.78	45.35	12.39	27.69	22.00	16.61	11.86	13.56	15.30	14.85	NA	11.99	NA	NA	NA
Accounts Payable Current		4.75	2.82	4.14	4.97	2.43	2.35	2.35	2.76	4.30	3.31	2.42	3.24	3.75	2.37	2.32	3.61	4.62	4.11	3.66	2.59	3.76	2.10	2.93	NA	2.51	NA	NA	NA
Taxes Payable Current		0.82	0.64	0.70	0.67	0.66	0.56	0.53	0.56	0.66	0.62	0.68	0.64	0.73	0.59	0.43	0.47	0.70	0.54	0.47	0.71	0.61	0.38	0.33	NA	0.32	NA	NA	NA
Accrued Liabilities Current		12.60	10.04	8.38	7.44	14.84	11.49	9.68	7.79	8.23	6.91	6.60	5.15	7.32	6.17	5.66	5.96	9.03	7.61	6.48	6.29	7.55	6.38	7.73	NA	7.51	NA	NA	NA
Other Liabilities Current		1.05	0.85	0.76	0.70	0.80	0.93	0.99	0.87	0.98	0.51	0.43	0.37	0.60	0.43	0.34	0.43	0.56	0.61	0.47	0.51	0.49	0.53	0.71	NA	0.39	NA	NA	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Long Term Debt		59.28	36.85	36.71	36.64	35.95	35.76	35.59	35.44	35.34	35.10	34.94	34.79	34.62	34.54	34.37	34.21	31.15	30.95	30.76	NA	30.39	30.20	30.00	NA	29.56	NA	NA	NA
Long Term Debt Noncurrent		59.28	36.85	36.71	36.64	22.83	27.01	31.21	35.44	35.34	NA	34.94	34.79	34.62	NA	NA	34.21	19.90	23.45	27.01	30.57	30.39	25.20	27.50	NA	29.56	NA	NA	NA
Operating Lease Liability Noncurrent		2.35	2.51	2.66	2.82	2.97	3.11	3.25	3.40	3.54	2.82	2.92	3.02	3.12	3.22	3.27	3.36	2.62	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Stockholders Equity		34.19	37.94	45.48	48.34	57.06	62.99	68.42	76.60	85.17	91.08	97.17	101.97	25.49	27.48	29.44	36.51	47.85	54.33	59.82	65.42	71.04	76.35	-205.27	-197.97	-192.65	NA	NA	NA
Common Stock Value		0.29	0.29	0.29	0.28	0.27	0.27	0.27	0.27	0.26	0.26	0.26	0.26	0.19	0.19	0.19	0.19	0.19	0.19	0.18	0.18	0.18	0.18	0.00	NA	0.00	NA	NA	NA
Additional Paid In Capital Common Stock		409.98	408.36	406.50	404.47	402.68	400.32	398.15	395.90	393.64	391.91	389.85	387.13	302.84	301.17	299.72	299.02	297.75	296.68	295.30	293.81	291.91	291.07	4.67	NA	4.29	NA	NA	NA
Retained Earnings Accumulated Deficit		-376.08	-370.70	-361.31	-356.41	-345.89	-337.60	-329.99	-319.57	-308.73	-301.10	-292.95	-285.42	-277.54	-273.88	-270.46	-262.70	-250.09	-242.53	-235.67	-228.57	-221.04	-214.90	-209.94	NA	-196.95	NA	NA	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Net Cash Provided By Used In Operating Activities		2.13	-10.12	-8.83	-15.21	-3.10	-6.51	-8.95	-12.18	-4.52	-8.52	-5.77	-9.17	-1.70	-3.56	-9.48	-13.65	-6.40	-7.66	-6.85	-9.57	-2.28	-4.92	-5.10	-8.30	0.31	-1.93	NA	NA
Net Cash Provided By Used In Investing Activities		-0.56	0.07	-0.64	-0.18	-0.50	9.27	-0.97	-1.07	-0.80	-7.93	-0.43	-0.68	-0.12	-0.13	-0.22	-0.27	-0.36	-0.06	-0.12	-0.27	-0.36	-0.14	-0.22	-0.30	-0.28	-0.17	NA	NA
Net Cash Provided By Used In Financing Activities		22.26	0.00	-0.06	0.50	0.24	0.00	0.01	-0.05	0.03	0.10	0.71	82.16	0.06	0.41	0.05	1.85	0.10	0.44	0.47	1.41	0.46	97.27	-0.49	-0.20	5.00	0.01	NA	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Net Cash Provided By Used In Operating Activities		2.13	-10.12	-8.83	-15.21	-3.10	-6.51	-8.95	-12.18	-4.52	-8.52	-5.77	-9.17	-1.70	-3.56	-9.48	-13.65	-6.40	-7.66	-6.85	-9.57	-2.28	-4.92	-5.10	-8.30	0.31	-1.93	NA	NA
Net Income Loss		-5.38	-9.39	-4.90	-10.52	-8.29	-7.61	-10.42	-10.84	-7.64	-8.15	-7.53	-7.88	-3.66	-3.42	-7.76	-12.61	-7.55	-6.87	-7.09	-7.53	-6.14	-4.96	-7.50	-5.50	-4.92	-3.75	-2.87	-4.51
Profit Loss		-5.38	-9.39	-4.90	-10.52	-8.29	-7.61	-10.42	-10.84	-7.64	-8.15	-7.53	-7.88	-3.66	-3.42	-7.76	-12.61	-7.55	-6.87	-7.09	-7.53	-6.14	-4.96	-7.50	-5.50	-4.92	-3.75	NA	NA
Depreciation Depletion And Amortization		0.50	0.50	0.49	0.52	0.60	0.39	0.34	0.32	0.29	0.22	0.27	0.28	0.20	0.21	0.23	0.30	0.30	0.31	0.25	0.20	0.21	0.21	0.32	0.14	0.14	0.15	NA	NA
Increase Decrease In Accounts Receivable		0.90	2.48	3.45	2.01	2.06	0.57	3.14	0.55	-0.04	1.26	2.04	-0.20	1.60	-1.07	0.45	-0.38	-0.98	0.72	1.17	0.05	0.34	0.56	0.44	0.01	0.36	0.36	NA	NA
Increase Decrease In Inventories		-1.64	2.73	-0.24	0.24	0.29	1.46	-0.18	1.02	1.57	0.20	-0.01	1.68	-0.06	0.45	0.45	0.10	-0.15	0.37	0.14	-0.06	-0.33	0.39	0.08	0.30	0.55	-0.05	NA	NA
Increase Decrease In Accounts Payable		1.98	-1.52	-0.91	2.48	0.23	0.06	-0.03	-2.23	1.12	0.53	-0.67	-0.69	1.25	0.07	-1.11	-1.30	0.29	0.24	1.25	-1.48	1.20	-0.51	-0.35	0.26	1.61	0.45	NA	NA
Share Based Compensation		1.63	1.85	2.03	1.80	2.11	2.18	2.20	2.25	1.70	1.96	2.01	2.20	1.52	1.05	0.65	1.20	0.98	0.94	1.02	0.50	0.38	1.03	0.19	0.14	0.20	0.10	NA	NA
Amortization Of Financing Costs		0.10	0.10	0.10	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.10	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.30	0.20	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Net Cash Provided By Used In Investing Activities		-0.56	0.07	-0.64	-0.18	-0.50	9.27	-0.97	-1.07	-0.80	-7.93	-0.43	-0.68	-0.12	-0.13	-0.22	-0.27	-0.36	-0.06	-0.12	-0.27	-0.36	-0.14	-0.22	-0.30	-0.28	-0.17	NA	NA
Payments To Acquire Productive Assets		0.88	0.55	0.70	0.23	0.50	0.73	0.97	1.07	0.80	0.44	0.43	0.68	0.12	0.13	0.22	0.27	0.36	0.06	0.12	0.27	0.36	0.14	0.22	0.30	0.28	0.17	NA	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Net Cash Provided By Used In Financing Activities		22.26	0.00	-0.06	0.50	0.24	0.00	0.01	-0.05	0.03	0.10	0.71	82.16	0.06	0.41	0.05	1.85	0.10	0.44	0.47	1.41	0.46	97.27	-0.49	-0.20	5.00	0.01	NA	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Revenues		20.31	17.88	17.61	15.54	18.20	16.50	16.33	14.18	15.02	13.80	14.20	12.29	15.58	12.45	9.74	11.48	17.36	16.00	16.57	12.73	15.63	13.74	13.25	10.15	12.11	10.49	10.31	7.53
Revenue From Contract With Customer Excluding Assessed Tax		20.31	17.88	17.61	15.54	18.20	16.50	16.33	14.18	15.02	13.80	14.20	12.29	15.58	12.45	9.74	11.48	17.36	16.00	16.57	12.73	15.63	13.74	13.25	10.15	12.11	10.49	10.31	7.53
Sales Revenue Net, Geographic Concentration Risk		20.31	17.88	17.61	15.54	18.20	16.50	16.33	14.18	15.02	13.80	14.20	12.29	15.58	12.45	9.74	11.48	17.36	16.00	16.57	12.73	15.63	13.74	13.25	10.15	12.11	10.49	10.31	NA
Neuro Star Advanced Therapy System,US, Sales Revenue Net, Product Category		4.52	3.60	4.49	3.85	4.62	3.93	4.38	3.64	2.81	2.61	2.58	1.75	3.62	2.54	2.34	2.59	5.41	4.62	4.63	3.35	4.75	3.91	3.57	2.37	NA	NA	NA	NA
Neuro Star Advanced Therapy System, Non Us, Sales Revenue Net, Product Category		0.06	0.26	0.06	0.26	0.35	0.10	0.05	0.31	0.31	0.31	0.28	0.21	0.22	0.22	0.31	0.10	0.10	0.47	0.47	0.07	0.42	0.00	0.22	NA	NA	NA	NA	NA
Other Product,US, Sales Revenue Net, Product Category		0.47	0.55	0.49	0.47	0.45	0.45	0.46	0.41	0.50	0.41	0.43	0.42	0.40	0.41	0.38	0.39	0.37	0.43	0.41	0.42	0.43	0.39	0.41	0.36	NA	NA	NA	NA
Other Product, Non Us, Sales Revenue Net, Product Category		0.22	0.14	0.14	0.13	0.19	0.13	0.13	0.18	0.13	0.12	0.10	0.15	0.15	0.10	0.05	0.12	0.12	0.13	0.10	0.09	0.09	0.09	0.08	0.15	NA	NA	NA	NA
Treatment Sessions,US, Sales Revenue Net, Product Category		14.88	13.06	12.31	10.64	12.45	11.86	11.29	9.47	11.24	10.26	10.80	9.63	11.03	9.08	6.55	8.19	11.24	10.25	10.85	8.78	9.91	9.22	8.92	7.24	NA	NA	NA	NA
Treatment Sessions, Non Us, Sales Revenue Net, Product Category		0.17	0.28	0.13	0.18	0.14	0.03	0.01	0.17	0.03	0.09	0.01	0.13	0.16	0.10	0.12	0.08	0.10	0.11	0.11	0.02	0.04	0.13	0.06	0.03	NA	NA	NA	NA
US, Sales Revenue Net, Product Category		19.87	17.21	17.29	14.96	17.51	16.24	16.13	13.52	14.56	13.28	13.81	11.80	15.05	12.03	9.27	11.18	17.03	15.29	15.89	12.55	15.09	13.52	12.90	9.97	NA	NA	NA	NA
US, Sales Revenue Net, Geographic Concentration Risk		19.87	17.21	17.29	14.96	17.51	16.24	16.13	13.52	14.56	13.28	13.81	11.80	15.05	12.03	9.27	11.18	17.03	15.29	15.89	12.55	15.09	13.52	12.90	9.97	11.84	10.40	10.22	NA
Non Us, Sales Revenue Net, Product Category		0.44	0.67	0.32	0.58	0.69	0.25	0.20	0.66	0.47	0.52	0.39	0.49	0.53	0.42	0.47	0.30	0.33	0.71	0.68	0.18	0.55	0.22	0.35	0.18	NA	NA	NA	NA
Non Us, Sales Revenue Net, Geographic Concentration Risk		0.44	0.67	0.32	0.58	0.69	0.25	0.20	0.66	0.47	0.52	0.39	0.49	0.53	0.42	0.47	0.30	0.33	0.71	0.68	0.18	0.55	0.22	0.35	0.18	0.27	0.09	0.08	NA

Plots across concepts

Line plots across dimensions of each concept